/

Kymera Therapeutics

Develops targeted protein degradation medicines to treat human diseases.

BiotechnologyPharmaceuticals kymeratx.com ↗

Company facts

Founded: 2016
Employees: 238
Headquarters: United States
Type: Public
Listed: NASDAQ: KYMR